-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al. -
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementPB Shah, FGP Welt, E Mahmud et al.
-
High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary SyndromeA Bularga, KK Lee, the High-STEACS Investigators et al.
-
Comparison in prevalence, predictors, and clinical outcome of VSR versus FWR after acute myocardial infarction: The prospective, multicenter registry MOODY trial-heart rupture analysisXue X, Chen SL; MOODY trial investigators.
-
Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studiesIannaccone M, D'ascenzo F, Piazza F et al.
-
Healed Culprit Plaques in Patients With Acute Coronary SyndromesFracassi F, Crea F, Jang IK et al.
-
Cardiac Shock Care Centers: JACC Review Topic of the WeekRab T, Ratanapo S, Kern KB et al.
-
Efficacy and Safety of Stents in ST-Segment Elevation Myocardial InfarctionP Chichareon, R Modolo, PW Serruys et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
